These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 824103)

  • 41. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 42. [Rifampicin and ethambutol in the treatment of tuberculosis in children and adolescents].
    Sibila S; Fierbinţeanu O
    Pediatria (Bucur); 1973; 22(4):361-6. PubMed ID: 4543407
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of primary tuberculosis].
    Gerbeaux J
    Rev Med Liege; 1974 Jan; 29(2):29-35. PubMed ID: 4846950
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 45. [Enormous subclavicular, mediastinal and retroperitoneal tuberculous lymphadenopathy in a young adult patient (author's transl)].
    Mannes P; Bosly A; Delporte F
    Acta Tuberc Pneumol Belg; 1971; 62(5):467-72. PubMed ID: 5163924
    [No Abstract]   [Full Text] [Related]  

  • 46. Re-emphasizing Thygeson's warning: conjunctival phlyctenulosis as presenting sign of impending clinical tuberculosis.
    Sharma K; Kalakoti P; Juneja R; Sahu S; Singh V; Subramanian PS
    Can J Ophthalmol; 2014 Dec; 49(6):e135-7. PubMed ID: 25433746
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 48. Rifampin in initial treatment of advanced pulmonary tuberculosis.
    Corpe RF; Sanchez ES
    Chest; 1972 Jun; 61(6):564-73. PubMed ID: 5032152
    [No Abstract]   [Full Text] [Related]  

  • 49. Editorial: Rifampin in the treatment of tuberculosis.
    Grzybowshi S
    Can Med Assoc J; 1974 May; 110(9):1002 passim. PubMed ID: 4823101
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethambutol regimen in renal tuberculosis.
    Wechsler H
    J Urol; 1975 Oct; 114(4):498-9. PubMed ID: 1235368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients.
    Galal SH; Khalil SH; el Husseiny W; Brock J
    Allerg Immunol (Leipz); 1988; 34(4):249-54. PubMed ID: 3147590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A study of 200 cases of active, recent pulmonary tuberculosis treated with rifampin-isoniazid. A follow-up history of one and one-half to three years.
    Constans P; Baron A; Parrot R; Coury C
    Chest; 1972 Jun; 61(6):539-49. PubMed ID: 4624276
    [No Abstract]   [Full Text] [Related]  

  • 53. [Quantitative evaluation of the dynamics of tubercular mediastinal adenopathy treated with rifampicin and ethambutol].
    Tonceanu S; Bazacliu E; Carp G; Varadi P; Ritter S; Simon F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(3):143-50. PubMed ID: 201006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psoas abscess due to retroperitoneal tuberculous lymphadenopathy.
    Perros P; Sim DW; MacIntyre D
    Tubercle; 1988 Dec; 69(4):299-301. PubMed ID: 3257007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lymphatic tuberculosis with an atypical presentation in a patient with myelodysplastic syndrome: an unusual association].
    Arenas M; Tovar A; Martínez V; Calduch JV; del Mar Segarra M; Mata B
    Enferm Infecc Microbiol Clin; 2000; 18(6):294-6. PubMed ID: 11075492
    [No Abstract]   [Full Text] [Related]  

  • 56. Prolonged renal failure after rifampin.
    Bansal VK; Bennett D; Molnar Z
    Am Rev Respir Dis; 1977 Jul; 116(1):137-40. PubMed ID: 879592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrogenic diabetes insipidus and tubulointerstitial nephritis during continuous therapy with rifampin.
    Quinn BP; Wall BM
    Am J Kidney Dis; 1989 Sep; 14(3):217-20. PubMed ID: 2773924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampin.
    Schonell M; Dorken E; Grzybowski S
    Can Med Assoc J; 1972 Apr; 106(7):783-6. PubMed ID: 4622757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy of tuberculosis.
    Pinsker KL; Koerner SK
    Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rifampin-induced severe thrombocytopenia in a patient with pulmonary tuberculosis.
    Kindelán JM; Serrano I; Jurado R; Villanueva JL; García-Lázaro M; García-Herola A; Torre Cisneros J
    Ann Pharmacother; 1994 Nov; 28(11):1304-5. PubMed ID: 7849351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.